Concepedia

Hugh Cowley

HC

Statistics

Publications

8

Citations

2.9K

H-Index

8

Active since

1994

Affiliations

Molecular Discovery (United Kingdom)(Current)

GlaxoSmithKline (United Kingdom)

St James's University Hospital

Hugh Cowley is an author at Molecular Discovery (United Kingdom) specializing in pharmacology, bioavailability, and biomarkers in sepsis.

Publications per year

1994–2001

8

Publications

8

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response

Margaret J Leckie, Anneke Ten Brinke, Jamey Khan et al. · The Lancet · 2000 · 1.8K citations

, , +13

Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction

Helen F. Goode, Hugh Cowley, B. E. Walker et al. · Critical Care Medicine · 1995 · 474 citations

, , +15

Absorption, Disposition, and Metabolism of Rosiglitazone, a Potent Thiazolidinedione Insulin Sensitizer, in Humans

Peter J. Cox, David Ryan, F. J. Hollis et al. · Drug Metabolism and Disposition · 2000 · 207 citations

, , +16

Plasma antioxidant potential in severe sepsis

Hugh Cowley, Pamela Bacon, Helen F. Goode et al. · Critical Care Medicine · 1996 · 205 citations

, , +16

Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome

Hugh Cowley, David Heney, A. J. H. Gearing et al. · Critical Care Medicine · 1994 · 178 citations

, , +17

1–5 of 8